A persistent, often progressive, lung disease, COPD results from chronic inflammation that leads to structural changes ...

Bronchiectasis is a clinical condition defined as a chronic, abnormal dilation of the bronchi accompanied by classical ...

Hashtags are like campfires: people gather around them to have conversations,' claims Twitter in its case study of Boehringer Ingelheim's (BI) COPD Twitter campaign. The 'fire' analogy is ...

Boehringer Ingelheim has announced an increase in sales ... approved for chronic obstructive pulmonary disease (COPD) and asthma, generated net sales of 2.4 billion euros, down 11.4% compared ...

The PREPOCOL study was sponsored by an educational contribution from Boehringer-Ingelheim and Pfizer, which did not participate in study design, sample collection, data analysis, or publication.

The global Chronic Obstructive Pulmonary Disease (COPD) treatment market is projected to experience steady growth over the ...

Although bronchial hyperresponsiveness to cholinergic agents is a main feature of asthma, the role of anticholinergic drugs in chronic asthma management has been largely underestimated. Several ...

Global Pleural Diseases Therapeutics MarketThe global market for pleural diseases therapeutics is projected to experience ...

Hosted by Boehringer Ingelheim, the ‘CRM Summit’, an expert engagement forum, and the ‘IMETA CRM Discussions for EXperts (MEDEX CRM)’, a scientific expert meeting, brought together healthcare ...

The Study to Understand Mortality and Morbidity in COPD (SUMMIT) is a randomised controlled trial conducted in patients with COPD and comorbid cardiovascular disease, designed to assess the ‘impact of ...

7 Department of Intensive Care Medicine, North Manchester General Hospital 8 Department of Intensive Care Medicine, Wythenshawe Hospital, Manchester 9 Department of Intensive Care Medicine, Hope ...